Supralip NT 145

Supralip NT 145

fenofibrate

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Fenofibrate (nanoparticles)
Indications/Uses
Severe hypertriglyceridaemia w/ or w/o low HDL cholesterol. Mixed hyperlipidaemia when a statin is contraindicated or not tolerated. Mixed hyperlipidaemia in patients at high CV risk (eg, dyslipidemia in DM) in addition to a statin when triglycerides & HDL cholesterol are not adequately controlled.
Dosage/Direction for Use
Administration
May be taken with or without food: Swallow whole, do not chew/crush.
Contraindications
Serious hepatic & renal insufficiency. Phototoxic reaction w/ fibrates or ketoprofen, gallbladder disease. Allergy to peanut or arachis oil or soya lecithin. Pregnancy & lactation. Childn.
Special Precautions
Treat secondary causes of hypercholesterolemia prior to fenofibrate therapy. For hyperlipidemic patients, estrogen may raise lipid values. Monitor liver & renal functions. Supralip NT 145 contains lactose & sucrose (not for patients w/ galactose or fructose intolerance).
Adverse Reactions
GI disturbances, elevation of transaminases, allergic skin reactions, muscular pains.
Drug Interactions
Potentiates action of anticoagulants. Cyclosporin.
ATC Classification
C10AB05 - fenofibrate ; Belongs to the class of fibrates. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Supralip NT 145 FC tab 145 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in